Kineta Executive's Stock Moves Signal Confidence Amid TuHURA Merger Deal
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Craig W. Philips, President and Secretary of Kineta, reported multiple securities transactions on June 23-25, 2025:
- Exercised 225,000 stock options at $0.36 per share on June 23
- Disposed of 47,647 shares at $0.26 per share through tax withholding (Form F)
- Acquired 60,300 new shares on June 25 at $0 cost
These transactions occurred following the approval of a merger agreement between Kineta and TuHURA Biosciences at a Special Meeting of Stockholders on June 23, 2025. The merger agreement triggered full vesting of Philips' options under the 2022 Equity Incentive Plan.
Post-transactions, Philips directly owns 298,464 shares and indirectly controls 34,654 shares through Whetstone Ventures LLC, where he serves as member manager with shared voting and dispositive power.
Positive
- None.
Negative
- None.
Insider Trade Summary
225,000 shares exercised/converted
Mixed
5 txns
Insider
PHILIPS CRAIG W.
Role
President and Secretary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 60,300 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 225,000 | $0.00 | -- |
| Exercise | Common Stock | 225,000 | $0.36 | $81K |
| Tax Withholding | Common Stock | 47,647 | $0.26 | $12K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 298,464 shares (Direct);
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 34,654 shares (Indirect, By Whetstone Ventures, LLC)
Footnotes (1)
- The Reporting Person is a member manager of Whetstone Ventures, LLC ("Whetstone") and shares voting and dispositive power over the shares held by Whetstone. Pursuant to the terms of (i) the Optionholder Treatment Agreement, dated June 16, 2025, by and between Kineta, Inc. (the "Company") and the Reporting Person, and (ii) the Agreement and Plan of Merger, dated as of December 11, 2024, by and among the Company, TuHURA Biosciences, Inc., a Nevada corporation ("TuHURA"), Hura Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of TuHURA, Hura Merger Sub II, a Delaware limited liability company and a wholly owned subsidiary of TuHURA, and Craig Philips, as representative of the stockholders of the Company, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025, as approved by the Company's stockholders at the Special Meeting of Stockholders held on June 23, 2025, the options granted to the Reporting Person under the 2022 Equity Incentive Plan became fully vested on June 23, 2025.
FAQ
What insider transactions did Craig Philips (KA's President) report on June 23, 2025?
On June 23, 2025, Craig Philips executed multiple transactions: He acquired 225,000 shares at $0.36 per share through option exercise (M), disposed of 47,647 shares at $0.26 per share (F), and on June 25, 2025, he acquired an additional 60,300 shares at $0 cost. After these transactions, he directly owns 298,464 shares and indirectly owns 34,654 shares through Whetstone Ventures, LLC.
How many KA stock options did Craig Philips exercise in the June 23, 2025 transaction?
Craig Philips exercised 225,000 stock options with an exercise price of $0.36 per share on June 23, 2025. These options were originally set to expire on April 13, 2034, but became fully vested on June 23, 2025 due to the TuHURA Biosciences merger agreement.
What is Craig Philips' total KA stock ownership after the June 2025 transactions?
Following the reported transactions, Craig Philips owns a total of 333,118 shares of KA stock, consisting of 298,464 shares held directly and 34,654 shares held indirectly through Whetstone Ventures, LLC, where he serves as a member manager with shared voting and dispositive power.
Why did KA's stock options vest early for Craig Philips in June 2025?
The stock options vested early on June 23, 2025, due to the Optionholder Treatment Agreement dated June 16, 2025, and the Agreement and Plan of Merger with TuHURA Biosciences, Inc. This accelerated vesting was approved by KA's stockholders at the Special Meeting of Stockholders held on June 23, 2025.